Free Trial

MiNK Therapeutics (INKT) Short Interest Ratio & Short Volume

MiNK Therapeutics logo
$0.71
-0.01 (-1.39%)
(As of 11/1/2024 ET)

MiNK Therapeutics Short Interest Data

MiNK Therapeutics (INKT) has a short interest of 65,300 shares, representing 0.65% of the float (the number of shares available for trading by the public). This marks a 34.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 92,050 shares to cover all short positions.

Current Short Interest
65,300 shares
Previous Short Interest
48,600 shares
Change Vs. Previous Month
+34.36%
Dollar Volume Sold Short
$43,424.50
Short Interest Ratio
1.7 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
39,540,000 shares
Float Size
10,020,000 shares
Short Percent of Float
0.65%
Today's Trading Volume
25,729 shares
Average Trading Volume
92,050 shares
Today's Volume Vs. Average
28%
Short Selling MiNK Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for MiNK Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INKT Short Interest Over Time

INKT Days to Cover Over Time

INKT Percentage of Float Shorted Over Time

MiNK Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202465,300 shares $43,424.50 +34.4%0.7%1.7 $0.67
9/30/202448,600 shares $36,450.00 -21.6%0.5%0.8 $0.75
9/15/202462,000 shares $48,081.00 +22.5%0.6%1.2 $0.78
8/31/202450,600 shares $40,986.00 -21.3%0.5%0.9 $0.81
8/15/202464,300 shares $52,790.30 +5.1%1.1%1 $0.82
7/31/202461,200 shares $57,528.00 -27.9%1.2%0.4 $0.94
7/15/202484,900 shares $96,786.00 -10.3%1.6%0.6 $1.14
6/30/202494,600 shares $89,794.32 -19.6%1.8%0.6 $0.95
6/15/2024117,600 shares $108,156.72 -31.4%2.2%0.6 $0.92
5/31/2024171,300 shares $166,161.00 -66.9%3.2%0.9 $0.97
5/15/2024516,900 shares $537,576.00 +490.7%5.2%2.8 $1.04
4/30/202487,500 shares $86,625.00 +80.4%0.9%0.9 $0.99
4/15/202448,500 shares $44,062.25 +18.0%0.5%0.5 $0.91
3/31/202441,100 shares $37,331.13 -11.6%0.4%0.4 $0.91
3/15/202446,500 shares $41,594.25 +12.6%0.5%0.8 $0.89
2/29/202441,300 shares $38,049.69 -76.4%0.4%0.7 $0.92
2/15/2024175,100 shares $162,843.00 -7.6%1.8%3.4 $0.93
1/31/2024189,400 shares $163,831.00 +8.3%2.0%3.8 $0.87
1/15/2024174,900 shares $172,976.10 -1.7%1.8%3.8 $0.99
12/31/2023178,000 shares $190,460.00 +237.8%1.9%4.6 $1.07
12/15/202352,700 shares $53,754.00 -66.3%0.6%1.2 $1.02
11/30/2023156,400 shares $164,220.00 +2.4%1.6%3.9 $1.05
11/15/2023152,700 shares $155,754.00 -19.7%1.6%3.4 $1.02
10/31/2023190,100 shares $193,902.00 +11.7%2.0%3.6 $1.02
10/15/2023170,200 shares $187,220.00 +6.7%1.8%3 $1.10
9/30/2023159,500 shares $175,450.00 -11.7%1.8%2.4 $1.10
9/15/2023180,600 shares $232,974.00 -7.7%1.9%2.5 $1.29
8/31/2023195,700 shares $283,765.00 -1.0%2.1%1.9 $1.45
8/15/2023197,600 shares $337,896.00 -31.4%2.0%1.8 $1.71
7/31/2023288,000 shares $538,560.00 +6.9%3.0%2.1 $1.87
7/15/2023269,500 shares $493,185.00 +1.7%2.8%1.4 $1.83
6/30/2023264,900 shares $556,290.00 +68.5%2.7%1.4 $2.10
6/15/2023157,200 shares $377,280.00 +2.0%1.6%0.9 $2.40
5/31/2023154,100 shares $271,216.00 -14.6%1.7%1.2 $1.76
5/15/2023180,500 shares $305,045.00 +70.4%1.9%1.5 $1.69
4/30/2023105,900 shares $189,561.00 +117.5%1.1%1.1 $1.79
4/15/202348,700 shares $107,627.00 +34.2%1.1%2.8 $2.21
3/31/202336,300 shares $68,788.50 -14.0%0.8%3.2 $1.90
3/15/202342,200 shares $84,822.00 +92.7%1.0%3.6 $2.01
2/28/202321,900 shares $44,457.00 -60.9%0.5%2.2 $2.03
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

2/15/202356,000 shares $112,560.00 -19.4%1.3%4.6 $2.01
1/31/202369,500 shares $159,155.00 -10.6%1.6%3.2 $2.29
1/15/202377,700 shares $183,372.00 -15.2%1.7%3.4 $2.36
12/30/202291,600 shares $239,076.00 -7.0%2.0%3.9 $2.61
12/15/202298,500 shares $217,685.00 -34.9%2.1%4 $2.21
11/30/2022151,400 shares $401,210.00 -7.4%3.3%5.2 $2.65
11/15/2022163,500 shares $501,667.05 +24.0%3.5%4.6 $3.07
10/31/2022131,900 shares $287,542.00 +3.2%2.8%0.3 $2.18
10/15/2022127,800 shares $241,542.00 -0.8%2.8%0.3 $1.89
9/30/2022128,800 shares $271,768.00 +25.1%2.8%0.3 $2.11
9/15/2022103,000 shares $269,860.00 -46.1%2.2%0.2 $2.62
8/31/2022191,200 shares $502,856.00 +15.3%4.2%0.4 $2.63
8/15/2022165,800 shares $563,720.00 +400.9%3.7%0.4 $3.40
7/31/202233,100 shares $43,361.00 +0.3%0.8%0.8 $1.31
7/15/202233,000 shares $42,570.00 -35.6%0.8%0.8 $1.29
6/30/202251,200 shares $72,192.00 -57.2%1.2%0.9 $1.41
6/15/2022119,500 shares $223,465.00 -1.6%2.9%2 $1.87
5/31/2022121,400 shares $188,170.00 +33.6%2.9%2 $1.55
5/15/202290,900 shares $117,261.00 -16.0%2.2%1.4 $1.29
4/30/2022108,200 shares $242,368.00 -32.5%2.6%1.7 $2.24
4/15/2022160,400 shares $469,972.00 +5.0%3.8%2.2 $2.93
3/31/2022152,800 shares $343,800.00 -2.4%3.7%2 $2.25
3/15/2022156,500 shares $355,255.00 -7.6%3.8%1.9 $2.27
2/28/2022169,400 shares $503,118.00 +5.2%4.2%1.9 $2.97
2/15/2022161,000 shares $457,240.00 -21.8%4.0%1.7 $2.84
1/31/2022205,800 shares $677,082.00 -11.3%5.1%2.2 $3.29
1/15/2022231,900 shares $735,123.00 +139.1%N/A2.2 $3.17
12/31/202197,000 shares $432,620.00 No Change2.4%0.9 $4.46

INKT Short Interest - Frequently Asked Questions

What is MiNK Therapeutics' current short interest?

Short interest is the volume of MiNK Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 65,300 shares of INKT short. 0.65% of MiNK Therapeutics' shares are currently sold short. Learn More on MiNK Therapeutics' current short interest.

What is a good short interest ratio for MiNK Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INKT shares currently have a short interest ratio of 2.0. Learn More on MiNK Therapeutics's short interest ratio.

What is a good short interest percentage for MiNK Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of MiNK Therapeutics' floating shares are currently sold short.

Is MiNK Therapeutics' short interest increasing or decreasing?

MiNK Therapeutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 65,300 shares, an increase of 34.4% from the previous total of 48,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is MiNK Therapeutics' float size?

MiNK Therapeutics currently has issued a total of 39,540,000 shares. Some of MiNK Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MiNK Therapeutics currently has a public float of 10,020,000 shares.

How does MiNK Therapeutics' short interest compare to its competitors?

0.65% of MiNK Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to MiNK Therapeutics: Celularity Inc. (6.35%), Elevation Oncology, Inc. (11.90%), Atara Biotherapeutics, Inc. (16.10%), Precision BioSciences, Inc. (5.77%), Cellectis S.A. (0.62%), Senti Biosciences, Inc. (2.06%), Benitec Biopharma Inc. (0.36%), AlloVir, Inc. (4.24%), FibroBiologics, Inc. (8.76%), Genenta Science S.p.A. (0.06%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short MiNK Therapeutics stock?

Short selling INKT is an investing strategy that aims to generate trading profit from MiNK Therapeutics as its price is falling. INKT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against MiNK Therapeutics?

A short squeeze for MiNK Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INKT, which in turn drives the price of the stock up even further.

How often is MiNK Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INKT, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:INKT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners